Lipid-based nanoparticles for cancer treatment

Mohammad A. Obeid, Rothwelle J. Tate, Alexander B. Mullen, Valerie A. Ferro

Research output: Chapter in Book/Report/Conference proceedingChapter

18 Citations (Scopus)


Lipid-based nanoparticles provide a new mode of cancer treatment by delivering drugs to the target site in order to improve the drug pharmacokinetics and/or reduce their toxicities. Several of these nanoparticle-based anticancer therapeutics are currently being investigated in clinical trials, with some already approved for clinical practice. In this chapter, we will highlight the main features of these nanoparticles and describe their types and classes. We will examine some of the approved formulations and some of those currently investigated in clinical trials. In addition, we will discuss the major techniques that are involved in their manufacturing and characterization, along with the major challenges in translating basic research to the clinic. Moreover, we will discuss the use of lipid-based nanoparticles in the delivery of short interfering RNA. These nanoparticles promise innovative and better anticancer medications development for clinical cancer treatment.

Original languageEnglish
Title of host publicationLipid Nanocarriers for Drug Targeting
EditorsAlexandru Mihai Grumezescu
Place of PublicationAmsterdam
Number of pages47
ISBN (Print)9780128136881, 9780128136874
Publication statusPublished - 18 Apr 2018


  • cancer treatment
  • drug delivery
  • formulation method
  • lipid-based nanoparticles
  • liposomes
  • micelles
  • niosomes
  • particles characterization


Dive into the research topics of 'Lipid-based nanoparticles for cancer treatment'. Together they form a unique fingerprint.

Cite this